More Medical News
Savient to cut jobs, names new CEO
7/9/2012

(Reuters) - Savient Pharmaceuticals Inc said it would cut about 35 percent of its workforce and named a new chief administrant as it struggles to stay afloat amid weak sales of its chronic gout drug Krystexxa. Shares of Savient rose as much as 8 perc...

More: - The rest...

Share |
Technorati Tags: ,
Filed under: ,
(Posted in Medical School)
Share and enjoy
  • Digg
  • del.icio.us
  • DZone
  • Netvouz
  • NewsVine
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • YahooMyWeb
Entry 1 of 19080
Last Page | Next Page
portfolio